However, the authors applied the inhibitor to block the cleavage and secretion of the synaptic adhesion molecule neuroligin-3 (NLGN3), and thereby, reduced its growth promoting function rather specific for glioma cells. The gene discussed is NLGN3; the disease is glioma.